NITI Aayog Member (Health) Dr V K Paul

Responding to a question at the weekly press conference, NITI Aayog Member (Health) Dr V K Paul said a candidate vaccine by Pune-based Gennova Biopharmaceuticals, which is entirely an Indian development, is in final clinical trial stages.…

NITI Aayog Member (Health) Dr V K Paul said all decisions on precaution doses are taken first and foremost based on the need. “The scientific need is the first part that drives it, then other considerations — programmatic and…